🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this project is to introduce way for treatment of patients with ...
Status
Unknown
Location
Ain Shams University
Start Date
2020-05-20
Trial ID
NCT04376788
A randomized, open-label, multicenter, three-arm clinical trial to study th...
Status
Unknown
Location
LifeFactors Zona Franca SAS
Start Date
2020-09
Trial ID
NCT04395170
Researchers are trying to assess the treatment potential and safety of anti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04325672
Treatments Being Tested
Due to the limitations of COVID-19 treatment and in the absence of licensed...
Status
Unknown
Location
Ministry Of Health
Start Date
2020-05-21
Trial ID
NCT04474340
Treatments Being Tested
In this study, investigators will determine whether the early addition of H...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2020-04-30
Trial ID
NCT04361253
Treatments Being Tested
A prospective, randomized, placebo-controlled, double-blinded, phase III cl...
Status
Terminated
Location
Universitas Hospital
Start Date
2020-09-21
Trial ID
NCT04516811
The investigators hypothesize that use of convalescent plasma donated from ...
Status
Terminated
Location
Inova Fairfax Medical Campus
Start Date
2020-06-06
Trial ID
NCT04502472
Treatments Being Tested
This study proposes to evaluate the therapeutic efficacy, immunologic effec...
Status
Terminated
Location
Norton Hospital
Start Date
2020-08-14
Trial ID
NCT04513158
Treatments Being Tested
Convalescent plasma has been shown to be safe and effective for treatment o...
Status
Completed
Location
Danderyd Hospital
Start Date
2020-05-07
Trial ID
NCT04384497
Treatments Being Tested
This is Phase 2 multi-center controlled randomized study to assess the effi...
Status
Completed
Location
NRC Institute of Immunology FMBA
Start Date
2021-04-27
Trial ID
NCT05184127
Treatments Being Tested